NAVELBINE is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Pierre Fabre Pharmaceuticals, Inc.. The primary component is Vinorelbine Tartrate.
| Product ID | 64370-532_7e013efa-e6a9-cb83-e053-2991aa0a8980 | 
| NDC | 64370-532 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | NAVELBINE | 
| Generic Name | Vinorelbine Tartrate | 
| Dosage Form | Injection | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 2005-11-15 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA020388 | 
| Labeler Name | Pierre Fabre Pharmaceuticals, Inc. | 
| Substance Name | VINORELBINE TARTRATE | 
| Active Ingredient Strength | 10 mg/mL | 
| Pharm Classes | Vinca Alkaloid [EPC],Vinca Alkaloids [CS] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2019-12-31 | 
| Marketing Start Date | 2005-11-15 | 
| Marketing End Date | 2021-10-31 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA020388 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2005-11-15 | 
| Marketing End Date | 2021-10-31 | 
| Marketing Category | NDA | 
| Application Number | NDA020388 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2005-11-15 | 
| Marketing End Date | 2021-10-31 | 
| Ingredient | Strength | 
|---|---|
| VINORELBINE TARTRATE | 10 mg/mL | 
| SPL SET ID: | 6d47c96a-7fdc-48ac-9250-41c5d3ecf8db | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 64370-532 | NAVELBINE | Vinorelbine Tartrate | 
| 0008-0045 | vinorelbine tartrate | vinorelbine tartrate | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  NAVELBINE  73632692  1452870 Live/Registered | PIERRE FABRE MEDICAMENT 1986-11-28 |